175 related articles for article (PubMed ID: 32564121)
21. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
22. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.
Albert X; Huertas I; Pereiró II; Sanfélix J; Gosalbes V; Perrota C
Cochrane Database Syst Rev; 2004; 2004(3):CD001209. PubMed ID: 15266443
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of an orally administered combination of hyaluronic acid, chondroitin sulfate, curcumin and quercetin for the prevention of recurrent urinary tract infections in postmenopausal women.
Torella M; Del Deo F; Grimaldi A; Iervolino SA; Pezzella M; Tammaro C; Gallo P; Rappa C; De Franciscis P; Colacurci N
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():125-128. PubMed ID: 27838537
[TBL] [Abstract][Full Text] [Related]
24. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.
Raz R; Stamm WE
N Engl J Med; 1993 Sep; 329(11):753-6. PubMed ID: 8350884
[TBL] [Abstract][Full Text] [Related]
25. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
Rozenberg S; Pastijn A; Gevers R; Murillo D
Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies.
Foon R; Toozs-Hobson P; Latthe P
Cochrane Database Syst Rev; 2012 Oct; 10():CD008224. PubMed ID: 23076941
[TBL] [Abstract][Full Text] [Related]
27. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.
Eriksen B
Am J Obstet Gynecol; 1999 May; 180(5):1072-9. PubMed ID: 10329858
[TBL] [Abstract][Full Text] [Related]
28. The Efficacy of Vaginal Laser and Other Energy-based Treatments on Genital Symptoms in Postmenopausal Women: A Systematic Review and Meta-analysis.
Li F; Picard-Fortin V; Maheux-Lacroix S; Deans R; Nesbitt-Hawes E; McCormack L; Abbott J
J Minim Invasive Gynecol; 2021 Mar; 28(3):668-683. PubMed ID: 32791349
[TBL] [Abstract][Full Text] [Related]
29. The effect of hormone therapy on the ocular surface and intraocular pressure for postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Hao Y; Xiaodan J; Jiarui Y; Xuemin L
Menopause; 2020 Aug; 27(8):929-940. PubMed ID: 32520901
[TBL] [Abstract][Full Text] [Related]
30. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
Nelson HD
JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
[TBL] [Abstract][Full Text] [Related]
31. Can vaginal lactobacillus suppositories help reduce urinary tract infections?
Shoureshi PS; Niino C; Eilber KS
Int Urogynecol J; 2023 Nov; 34(11):2713-2718. PubMed ID: 37392226
[TBL] [Abstract][Full Text] [Related]
32. A Cost Savings Analysis of Topical Estrogen Therapy in Urinary Tract Infection Prevention Among Postmenopausal Women.
Houston CG; Azar WS; Huang SS; Rubin R; Dorris CS; Sussman RD
Urol Pract; 2024 Mar; 11(2):257-266. PubMed ID: 38154005
[TBL] [Abstract][Full Text] [Related]
33. [Oestrogen for prevention of recurrent urinary tract infections in postmenopausal women--a survey of a Cochrane review].
Brostrøm S; Lose G
Ugeskr Laeger; 2009 Aug; 171(36):2568-71. PubMed ID: 19732549
[TBL] [Abstract][Full Text] [Related]
34. Comparison of sublingual therapeutic vaccine with antibiotics for the prophylaxis of recurrent urinary tract infections.
Lorenzo-Gómez MF; Padilla-Fernández B; García-Cenador MB; Virseda-Rodríguez ÁJ; Martín-García I; Sánchez-Escudero A; Vicente-Arroyo MJ; Mirón-Canelo JA
Front Cell Infect Microbiol; 2015; 5():50. PubMed ID: 26090341
[TBL] [Abstract][Full Text] [Related]
35. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
36. Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis.
Price JR; Guran LA; Gregory WT; McDonagh MS
Am J Obstet Gynecol; 2016 Nov; 215(5):548-560. PubMed ID: 27457111
[TBL] [Abstract][Full Text] [Related]
37. The efficacy and safety of ospemifene in treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy: a systematic review and meta-analysis.
Cui Y; Zong H; Yan H; Li N; Zhang Y
J Sex Med; 2014 Feb; 11(2):487-97. PubMed ID: 24251418
[TBL] [Abstract][Full Text] [Related]
38. [Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women].
Xu R; Wu Y; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):531-3. PubMed ID: 11769665
[TBL] [Abstract][Full Text] [Related]
39. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women.
Ismail SI; Bain C; Hagen S
Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855
[TBL] [Abstract][Full Text] [Related]
40. The detection and management of vaginal atrophy.
Johnston SL; Farrell SA; Bouchard C; Farrell SA; Beckerson LA; Comeau M; Johnston SL; Lefebvre G; Papaioannou A;
J Obstet Gynaecol Can; 2004 May; 26(5):503-15. PubMed ID: 15151738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
